[1]

Zhao S, Zhang L, Gu Z, et al. Clinical manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma: single-center experience with 18 patients[J/OL]. Onco Targets ther, 2018, 11: 555-561[2018-09-05]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790107. DOI: 10.2147/OTT.S147275.

[2] 唐光才.肺淋巴瘤的影像学表现[J].内科急危重症杂志, 2015, 21 (2):92-95. DOI:10.11768/nkjwzzzz20150204.
Tang GC. Imaging findings of pulmonary lymphoma[J]. J Inter Intensive Med, 2015, 21 (2):92-95.  doi: 10.11768/nkjwzzzz20150204
[3] Bai Y, Liang W. CT and PET/CT findings of primary pulmonary diffuse large B-cell lymphoma:One case report and literature review[J]. Medicine (Baltimore), 2017, 96 (47):e8876. DOI:10.1097/MD.0000000000008876.
[4] Yao D, Zhang L, Wu PL, et al. Clinical and misdiagnosed analysis of primary pulmonary lymphoma:a retrospective study[J]. BMC Cancer, 2018, 18 (1):281. DOI:10.1186/s12885-018-4184-1.
[5] Cordier JF, Chailleux E, Lauque D, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients[J]. Chest, 1993, 103 (1):201-208.  doi: 10.1378/chest.103.1.201
[6] Dong Y, Zeng M, Zhang B, et al. Significance of imaging and clinical features in the differentiation between primary and secondary pulmonary lymphoma[J]. Oncol Lett, 2017, 14 (5):6224-6230. DOI:10.3892/ol.2017.6962.